Journal
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY
Volume 22, Issue 1, Pages 4-9Publisher
SPRINGER INDIA
DOI: 10.1007/BF02912873
Keywords
Congestive heart failure; B-Type Natriuretic peptide; Amino terminal pro brain natriuretic peptide; Left ventricular ejection fraction; Myocardial Infarction
Categories
Ask authors/readers for more resources
The burden of disease in patients with congestive heart failure is high. The future of BNP looks promising as it may be a better diagnostic tool for the diagnosis of CHF in developing countries in new millennium. Natriuretic peptide hormones, a family of vasoactive peptides with many favourable physiological properties, have emerged as important contenders for development of diagnostic tools and therapeutic agents in cardiovascular disease. Measurement of B-type natriuretic peptide has become as an easy-to-perform bedside test. The clinical and diagnostic significance of the measurement of plasma Nt-proBNP in the diseases of the cardiovascular system with particular emphasis on the assessment of patients with heart failure and their effects on predicting survival rate. The plasma levels of Nt-proBrain Natriuretic peptide responds more vigorously after myocardial infarction than those of other natriuretic peptides. This article is an attempt to give a short overview on the utility of BNP-blood levels for the diagnosis and treatment of heart failure
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available